CLINICAL_TRIALS
trial_result
· 2019-05-07
Clinical Trial Update: Prophylactic Administration of Levosimendan in Patients Undergoing Coronary Surgery [Phase 4]
Summary
Phase 4 trial update on prophylactic use of levosimendan in patients undergoing coronary surgery.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AHEPA University Hospital | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED